CAI
Caris Life Sciences, Inc. Common Stock
NASDAQ: CAI · HEALTHCARE · BIOTECHNOLOGY
$17.77
-3.63% today
Updated 2026-04-29
Market cap
$5.02B
P/E ratio
—
P/S ratio
6.19x
EPS (TTM)
$-3.22
Dividend yield
—
52W range
$16 – $43
Volume
2.3M
Caris Life Sciences, Inc. Common Stock (CAI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $29.41M | $8.38M | $-266000.00 | $27.44M | $30.80M | $42.42M | $72.11M | $106.83M | $124.19M | $139.69M | $147.37M | $129.26M | $155.19M | $179.77M | $254.00M | $277.02M | $-285.71M | $-276.10M | $-245.20M | $83.16M |
| Capital expenditures | $350000.00 | $45.85M | $219.67M | $204.30M | $31.35M | $206.83M | $491.93M | $524.60M | $312.20M | $307.31M | $389.41M | $251.25M | $502.18M | $812.84M | $319.14M | $219.45M | $42.26M | $22.32M | $8.44M | $16.26M |
| Depreciation | $14.86M | $2.87M | $10.77M | $17.54M | $18.93M | $22.40M | $35.33M | $49.75M | $68.41M | $78.83M | $114.23M | $106.68M | $113.26M | $123.48M | $113.93M | $110.65M | $48.25M | $49.00M | $48.91M | — |
| Stock-based comp | — | — | — | $1.00M | $992000.00 | $1.07M | $1.12M | $1.29M | $1.54M | $1.89M | $1.92M | $1.73M | $2.09M | $2.87M | $2.76M | $1.77M | $22.90M | $15.24M | $18.64M | $70.01M |
| Free cash flow | $29.06M | $-37.48M | $-219.93M | $-176.86M | $-555000.00 | $-164.41M | $-419.82M | $-417.77M | $-188.02M | $-167.62M | $-242.04M | $-121.99M | $-346.98M | $-633.07M | $-65.14M | $57.57M | $-327.96M | $-298.42M | $-253.64M | $66.89M |
| Investing cash flow | $-8.23M | $7.84M | $-83.03M | $-77.61M | $3.69M | $-157.21M | $-430.14M | $-461.22M | $-266.81M | $-225.35M | $-305.25M | $-181.60M | $-411.75M | $-663.34M | $-271.87M | $-33.97M | $-282.99M | $214.77M | $52.93M | — |
| Financing cash flow | $-19.04M | $-272000.00 | $71.37M | $70.66M | $-49.01M | $115.02M | $358.05M | $358.08M | $172.10M | $95.14M | $156.54M | $46.60M | $245.63M | $512.35M | $-108.48M | $-249.88M | $10.45M | $10.13M | $200.29M | — |
| Dividends paid | — | — | $804000.00 | — | — | — | — | — | — | — | — | — | — | $3.26M | $8.83M | $17.71M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |